English · Not set Change ▾

Language Location Show all languages

Live scores ticker: On · Turn off

Markets ticker: Off · Turn on

Saved in a cookie on this device (and in your account when you are logged in). We never store your IP address.

Entities › name

Pfizer

6 headlines · 6 outlets · 2020-11-18 → 2026-10-05 · Wikipedia ↗ · 🔒 Follow

Latest coverage

Investor's Business Daily ·5h ago ☆

Country: United States

Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine Study

Vaxcyte stock catapulted Monday after its experimental pneumococcal vaccine proved it's not inferior to marketed shots from Pfizer and Merck. The post Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine Study appeared first on Investor's Business Daily .

Health Markets World Details Archived copy ↗

STAT ·6h ago ☆

Country: United States

STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market

Vaxcyte said its experimental pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up the biotech to compete with Pfizer and Merck.

Health Details Archived copy ↗

LifeSiteNews ·Oct 2, 2026 ☆

Country: Canada

Florida sues Pfizer for deceiving public about COVID vaccine safety

Florida Republican Attorney General James Uthmeier accused Pfizer and CEO Albert Bourla of hiding the health risks associated with COVID-19 shots that led to thousands of deaths and injuries.

Health Politics World Details Archived copy ↗

Pfizer

Latest coverage

Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine Study

STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market

Florida sues Pfizer for deceiving public about COVID vaccine safety

Explore

News

Watch & listen

Understand

Explore

Join

Banana News

Upgrade to unlock this

Keyboard shortcuts

Move

Go

Everywhere